CYP2W1 is induced by the AhR and ARNT pathway, as shown in experiments in which treatment of MDA-MB-468 and MCF7 breast cancer cells with AhR ligands such as 5F-203 and GW-610 increased expression of CYP2W1 [13,66]. Here, AHR is linked to breast carcinoma.